Sabine Matou-Nasri

14PUBLICATIONS
34CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNanomaterialsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 02, 2026
In vitro study and in silico reveal Teucrium Polium L. methanolic extract as an apoptosis inducer and a potential Bcl-2 inhibitor for breast cancer.

|Apr 27, 2026
Herbal Melanin Inhibits Colorectal Cancer Cell Motility, Invasiveness, and Epithelial-Mesenchymal Transition, Associated with u-PAR Downregulation Through JNK and ERK Pathways.

|Oct 28, 2025
Reticuline and Coclaurine Exhibit Vitamin D Receptor-Dependent Anticancer and Pro-Apoptotic Activities in the Colorectal Cancer Cell Line HCT116.

Hind A Alghamdi, Sahar S Alghamdi, Maryam Hassan Al-Zahrani

|Mar 28, 2025
Targeting p70S6K1 Inhibits Glycated Albumin-Induced Triple-Negative Breast Cancer Cell Invasion and Overexpression of Galectin-3, a Potential Prognostic Marker in Diabetic Patients with Invasive Breast Cancer.

Fatimah Alanazi, Abdulmonem A Alsaleh, Mariam K Alamoudi

|Mar 27, 2025
Advances in Materials Science for Precision Melanoma Therapy: Nanotechnology-Enhanced Drug Delivery Systems.

Sivakumar S Moni, Jobran M Moshi, Sabine Matou-Nasri

|Sep 28, 2024
A Benzimidazole-Based N-Heterocyclic Carbene Derivative Exhibits Potent Antiproliferative and Apoptotic Effects against Colorectal Cancer.

Sarah Al-Nasser, Maha Hamadien Abdulla, Noura Alhassan

Pageof 3

Frequent Collaborators

5 joint publications

Sahar S Alghamdi

3 joint publications

Rasha Suliman

3 joint publications

Hamad Al-Eidi

2 joint publications

Zeyad I Alehaideb